Last update 21 Nov 2024

CPD-1224

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
ALK x BTK
Mechanism
ALK inhibitors(Anaplastic lymphoma kinase inhibitors), BTK inhibitors(Tyrosine-protein kinase BTK inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
Diffuse Large B-Cell LymphomaNeoplasms
Inactive Indication-
Originator Organization
Harvard Medical SchoolHarvard Medical School
Active Organization
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Shanghai Fosun Pharmaceutical (Group) Co., Ltd.WuXi AppTec Co., Ltd.WuXi AppTec Co., Ltd.Harvard Medical SchoolHarvard Medical School
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure

Molecular FormulaC43H47ClN8O7S
InChIKeyYROLXKJYDUJWRK-UHFFFAOYSA-N
CAS Registry2891620-68-9

Related

100 Clinical Results associated with CPD-1224
Login to view more data
100 Translational Medicine associated with CPD-1224
Login to view more data
100 Patents (Medical) associated with CPD-1224
Login to view more data
1
Literatures (Medical) associated with CPD-1224
27 Apr 2023Journal of medicinal chemistryQ1 · MEDICINE
Catalytic Degraders Effectively Address Kinase Site Mutations in EML4-ALK Oncogenic Fusions.
Q1 · MEDICINE
100 Deals associated with CPD-1224
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diffuse Large B-Cell LymphomaPreclinical
CN
WuXi AppTec Co., Ltd.WuXi AppTec Co., Ltd.
17 Apr 2023
Diffuse Large B-Cell LymphomaPreclinical
CN
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
17 Apr 2023
NeoplasmsPreclinical
US
Harvard Medical SchoolHarvard Medical School
10 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free